I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
Advinus Therapeutics of India Selects Provantis 8 to Automate Drug Development Processes
Provantis 8™ Solution is Chosen from Comprehensive Competitive Evaluation
CONSHOHOCKEN, PA – December 22, 2006 - - Instem, a premier global information solutions provider, announced today that Advinus Therapeutics has chosen Provantis 8™ as their exclusive pre-clinical solution.
Advinus Therapeutics, located in Pune and Bangalore, India, is a pharmaceutical R&D organization focused on drug discovery while also providing comprehensive pre-clinical and clinical development services within the pharmaceutical and agrochemical sectors.
To enhance client services, attract western business and support GLP compliance, Advinus began evaluating solution providers in late 2005.
“We selected Provantis™ because of Instem’s proven record for successful on-site deployments and quality-focused programs designed to enhance and maximize the use of their solution,” comments Dr. Nimish Vachharajani, Head of Pharmaceutical and Agro Chemical Development at Advinus. “A number of our current and potential clients also use Provantis which would create a seamless interface between companies.”
Beginning in early 2007, Instem will be providing Advinus with Provantis 8™ Installation, Validation, Training and Go-Live Support services at their state of the art Bangalore facility.
Advinus also recently announced the establishment of a Drug Discovery and Development collaboration with Merck, in which the two companies will be working together to develop drug candidates for metabolic disorders.
“We are honored to assist Advinus in their mission to become the leading life sciences R&D organization from India, as judged by the quality of its leadership and people, programs and productivity,” comments Gregor Grant, Instem’s VP of Global Business Development. “It’s wonderful to see Instem again prevailing in a competitive evaluation over other respected organizations. Beyond functionality and beyond price, our clients confirm that one of our strongest differentiators is our people and our service.”
Provantis™ is a modern, fully integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies. From single-user Pathologists to full-function global Toxicology/Pathology laboratories, Provantis™ streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
Provantis™ 8, which was showcased at Instem’s International Conference in November, contains major enhancements to the Reproductive Toxicology, Animal Management and Fetal Pathology modules along with new extensive open reporting capabilities not found in other competing systems.
Instem solutions are offered through traditional on-site deployments as well as Instem's Web-based hosted application model, which is designed, priced and professionally managed as an on-line service for organizations wanting to reduce IT complexities and maximize budgets without the need for on-site hardware or software.
Instem's customer base consists of the leading pharmaceutical, chemical and contract research organizations, including government and privately funded programs across sites worldwide.
About Advinus
Advinus is an emerging company with deep capabilities in drug discovery and contract services for pharmaceutical and agrochemical companies. It is backed by the Tatas, India's largest and most respected business house, and led by executives with extensive international experience in pharmaceutical R&D. Advinus is uniquely focused on Pharmaceutical R&D with no Generics or API focus. Advinus Discovery focuses on Metabolic Diseases, Inflammation and Neglected diseases. The company works with internationally reputed partners to deliver value from innovation. The Discovery unit is fully integrated from hit to preclinical candidate. Advinus Development offers an integrated service platform for process chemistry, DMPK, clinical pharmacology, safety assessment, analytical R&D, bio-analytical and formulation development. For company information, visit Advinus on the World Wide Web at www.advinus.com
About Instem
Instem is a world-leading information solutions provider for the Life Sciences – accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products.
Established in 1969, Instem has offices in the United States and Europe with its solutions supported in fifteen countries. Instem serves large multi-national corporations and smaller organizations in overcoming the challenges of managing information and provides solutions that help them further their missions while creating a competitive advantage.
For more information on Instem and its solutions, please visit www.instem.com or contact them by email at info@instem.com.
Press Contact:
Gary E. Mitchell, VP Global Marketing, Instem US HQ
Tel: (610) 941-0990
Email: gary.mitchell@instem.com
All trademarks used are properties of their respective owners.
Links
Accessibility
Contact Us
© 2001 - 2010 Instem - All rights reserved